n(g)-iminoethylornithine has been researched along with Cerebral Ischemia in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (66.67) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amantea, D; Blandini, F; Demartini, C; Greco, R; Tassorelli, C; Zanaboni, AM | 1 |
| Clarkson, AN; Connor, BJ; Sun, Y; Van Slooten, AR | 1 |
| Ay, H; Dalkara, T; Kirazli, S; Kocaefe, C; Moskowitz, MA; Ozcebe, O; Ozgüç, M; Qui, J; Topalkara, K; Yemisci, M | 1 |
| Can, A; Dalkara, T; Gursoy-Ozdemir, Y; Topalkara, K; Vural, A; Yemisci, M | 1 |
| Chan, P; Cheung, RT; Fung, PC; Lee, W; Liu, KJ; Ma, S; Shen, J; Tong, Y | 1 |
| Cheng, H; Fu, YT; Huang, SS; Hung, LM; Liu, HY; Nien, MW; Tsai, SK; Zhang, FB | 1 |
1 trial(s) available for n(g)-iminoethylornithine and Cerebral Ischemia
| Article | Year |
|---|---|
Statin potentiates human platelet eNOS activity without enhancing eNOS mRNA and protein levels.
Topics: Adult; Aged; Aged, 80 and over; Arginine; Bleeding Time; Blood Platelets; Brain Ischemia; Enzyme Inhibitors; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Nitric Oxide; Nitric Oxide Synthase Type III; Ornithine; Platelet Aggregation; Pravastatin; RNA, Messenger; Stroke; Treatment Outcome | 2008 |
5 other study(ies) available for n(g)-iminoethylornithine and Cerebral Ischemia
| Article | Year |
|---|---|
Endothelial nitric oxide synthase inhibition triggers inflammatory responses in the brain of male rats exposed to ischemia-reperfusion injury.
Topics: Animals; Brain; Brain Ischemia; Enzyme Inhibitors; Inflammation; Inflammation Mediators; Male; Nitric Oxide Synthase Type III; Ornithine; Rats; Rats, Wistar; Reperfusion Injury | 2018 |
L-NIO as a novel mechanism for inducing focal cerebral ischemia in the adult rat brain.
Topics: Animals; Blood-Brain Barrier; Brain Infarction; Brain Ischemia; Corpus Striatum; Disease Models, Animal; Dizocilpine Maleate; Dose-Response Relationship, Drug; Enzyme Inhibitors; Gene Expression Regulation; Jugular Veins; Male; Movement Disorders; Nerve Degeneration; Nerve Tissue Proteins; Neurons; Neuroprotective Agents; Ornithine; Rats; Rats, Sprague-Dawley; Time Factors | 2015 |
Pericyte contraction induced by oxidative-nitrative stress impairs capillary reflow despite successful opening of an occluded cerebral artery.
Topics: Animals; Brain Ischemia; Capillaries; Cell Size; Enzyme Inhibitors; Mice; Mice, Knockout; Microscopy, Fluorescence; Microscopy, Interference; Middle Cerebral Artery; Nitric Oxide Synthase Type I; Nitric Oxide Synthase Type III; Ornithine; Oxidative Stress; Pericytes; Reactive Nitrogen Species; Reactive Oxygen Species; Reperfusion Injury | 2009 |
Nitric oxide down-regulates caveolin-1 expression in rat brains during focal cerebral ischemia and reperfusion injury.
Topics: Animals; Brain Ischemia; Caveolin 1; Enzyme Inhibitors; Gene Expression Regulation; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase; Ornithine; Rats; Rats, Sprague-Dawley; Reperfusion Injury | 2006 |
Resveratrol neuroprotective effects during focal cerebral ischemia injury via nitric oxide mechanism in rats.
Topics: Animals; Brain; Brain Ischemia; Carotid Arteries; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Inhibitors; Infarction, Middle Cerebral Artery; L-Lactate Dehydrogenase; Ligation; Male; Malondialdehyde; Middle Cerebral Artery; Neuroprotective Agents; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Ornithine; Rats; Rats, Long-Evans; Resveratrol; RNA, Messenger; Stilbenes; Up-Regulation | 2007 |